Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol
The highest standards of quality are followed in the manufacturing of all our treatments For Best Result: For faster results, the right dosage must be determined by the body weight and skin tone of each individual
Ferroptosis contributes not only to the endocrine and metabolic disturbances in PCOS but also directly to its reproductive impairments
Certificate of Analysis Certificates of Analysis Janoshik Third-party tested Independent analytical lab Frequently Asked Questions The KLOW Blend combines four peptides: GHK-Cu, BPC-157, TB-500, and KPV
The maximum single dose for adults should not exceed 1000 mg, and the daily total should generally not exceed the equivalent of 34 grams(depending on guidelines and patient factors)
